Clinical Trials Directory

Trials / Completed

CompletedNCT01417286

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This phase II trial studies how well giving accelerated radiation therapy (RT) after surgery works in treating patients with breast cancer. RT uses high energy x rays to kill tumor cells. Giving RT after surgery may kill any remaining tumor cells

Detailed description

PRIMARY OBJECTIVES: I. Freedom from local failure and freedom from regional failure. SECONDARY OBJECTIVES: I. Acute toxicity and late toxicity using previously published toxicity scales. II. To identify co-variates responsible for poor cosmetic outcome in women with reconstructed chest walls when treated with accelerated, hypofractionated radiotherapy. III. To correlate toxicity, cosmesis, and local control with molecular markers. OUTLINE: Patients undergo hypofractionated accelerated RT over 11 weekdays (for 15 elapsed days) within 21-63 days after last surgery or last course of chemotherapy. Treatment continues in the absence of disease progression or unacceptable toxicity. After completion of study treatment, patients are followed up at 2-8 weeks, every 3-6 months for 3 years, every 6-12 months for 2 years, and then annually thereafter.

Conditions

Interventions

TypeNameDescription
RADIATIONExternal beam radiation therapyHypofractionated accelerated radiation therapy over 11 days

Timeline

Start date
2010-12-21
Primary completion
2020-02-20
Completion
2020-02-20
First posted
2011-08-16
Last updated
2023-04-20
Results posted
2023-04-20

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01417286. Inclusion in this directory is not an endorsement.